North America Excipients Market, By Origin (Organic, Inorganic), Category (Primary Excipients, Secondary Excipients), Products (Polymers, Sugars, Alcohols, Minerals, Gelatin, Others), Chemistry Type (Plant, Animals, Synthetic, Minerals), Chemical Synthesis (Lactose Monohydrate, Sucralose, Polysorbate, Benzyl Alcohol, Cetosteary Aclohol, Soy Lecithin, Pregelatinized Starch, Others), Functionality (Binders and Adhesives, Disintegrants, Coating Material, Disintegrants, Solubilizers, Flavors, Sweetening Agents, Diluents, Lubricants, Buffers, Emulsifying Agents, Preservatives, Antioxidants, Sorbents, Solvents, Emollients, Glidients, Chelating Agents, Antifoaming Agents, Others), Dosage Form (Solid, Semi-Solid, Liquid), Route of Administration (Oral Excipients, Topical Excipients, Parenteral Excipients, Other Excipients), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Formulators, Research Organization and Academics, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2028
Market Analysis and Insights: North America Excipients Market
The excipients market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.9% in the forecast period of 2021 to 2028 and is expected to reach USD 6,296.82 million by 2028. Increasing demand for alternative routes of delivery/dosage forms and increasing need for pharmaceutical excipients across varied therapeutic areas are the major drivers which propelled the demand of the excipients market in the forecast period.
Pharmaceutical excipients involve everything in a drug except that of the active pharmaceutical ingredients. These molecules don’t possess any medicinal property and are ultimately used for enhancing the physiological absorption of the drug. Excipients are inert in nature and it allows the drug molecule to apply to patients in the right form.
The technological advancements in multifunctional excipients act as a driver for the excipients market growth in the forecast period. The long duration of the drug development process is expected to hinder the excipients market in the forecast period. The strategic initiatives by market players act as an opportunity for the growth of the excipients market. The safety consideration in storage & transportation acts as a challenge for the growth of the excipients market.
The excipients market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the excipients market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Excipients Market Scope and Market Size
The excipients market is categorized into ten notable segments which are based on the origin, category, products, chemistry type, chemical synthesis, functionality, dosage forms, route of administration, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of origin, the excipients market is segmented into organic and inorganic. In 2021, organic origin holds the highest market share due to non-toxic characteristic of organic chemicals used as excipients.
- On the basis of category, the excipients market is segmented into primary excipients and secondary excipients. In 2021, primary excipients segment is dominating the market as the segment includes fillers, adhesives, lubricants and other crucial excipients.
- On the basis of products, the excipients market is segmented into polymers, sugars, alcohols, minerals, gelatin and others. In 2021, polymers segment is dominating the market because polymers are used as gelatin shells in the manufacturing of capsules.
- On the basis of chemistry type, the excipients market is segmented into plant, animals, synthetic and minerals. In 2021, plant segment is dominating the market due to less expensive, non-toxic nature, biodegradable in nature and do not show any adverse effects of side effect on the human beings.
- On the basis of chemical synthesis, the excipients market is segmented into lactose monohydrate, sucralose, polysorbate, benzyl alcohol, cetosteary aclohol, soy lecithin, pregelatinized starch and others. In 2021, lactose monohydrate segment is dominating the market due to its multiple properties.
- On the basis of functionality, the excipients market is segmented into binders and adhesives, disintegrants, coating material, disintegrants, solubilizers, flavors, sweetening agents, diluents, lubricants, buffers, emulsifying agents, preservatives, antioxidants, sorbents, solvents, emollients, glidients, chelating agents, antifoaming agents and others. In 2021, binders and adhesives segment is dominating the market due to its properties.
- On the basis of dosage forms, the excipients market is segmented into solid, semi-solid and liquid. In 2021, solid segment is dominating the market as most of the excipients are used in manufacturing of solid dosage form.
- On the basis of route of administration, the excipients market is segmented into oral excipients, topical excipients, parenteral excipients and other excipients. In 2021, oral excipients segment dominates in the market as majority of drugs including the first line therapy are available in the oral form with the highest effectiveness having strong onset of action.
- On the basis of end user, the excipients market is segmented into pharmaceutical and biopharmaceutical companies, contract formulators, research organization and academics and others. In 2021, pharmaceutical and biopharmaceutical companies segment dominates in the market as most of the excipients are used in pharmaceutical and biopharmaceutical companies because these companies are responsible for the production of medicines in all dosage forms such as solid, semi-solid and liquid.
- On the basis of distribution channel, the excipients market is segmented into direct tender, retail sales and others. In 2021, direct tender segment is dominating in the market as it is the primary source of distribution of excipients.
North America Excipients Market Country Level Analysis
North America excipients market is analysed and market size information is provided based on the country, origin, category, products, chemistry type, chemical synthesis, functionality, dosage forms, route of administration, end user and distribution channel as referenced above.
The countries covered in the North America excipients market report are the U.S., Canada and Mexico.
The U.S. is dominating in the North America excipients market with the substantial CAGR in the forecast period due to innovations in biopharmaceuticals, rising focus on orphan drugs and technological advancements in multifunctional excipients.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Strategic Initiatives by Market Players Is creating new opportunities in the Excipients Market
The excipients market also provides you with detailed market analysis for every country growth in excipients, impact of advancement in excipients and changes in regulatory scenarios with their support for the excipients market. The data is available for historic period 2011 to 2019.
Competitive Landscape and Excipients Market Share Analysis
The excipients market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to North America excipients market.
The major companies covered in the North America excipients market report are DOW, Roquette Frères, JRS Pharma, Evonik Industries AG, The Lubrizol Corporation (a subsidiary of Berkshire Hathaway Inc.), BASF SE, Ashland, Kerry Group PLC, Shin-Etsu Chemical Co., Ltd., Colorcon, Chemische Fabrik Budenheim, Peter Greven GmbH & Co. KG, ADM, Croda International Plc, BENEO, Avantor, Inc., Omya AG, Pfanstiehl, Inc., MEGGLE Group Wasserburg among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launches and agreements are also initiated by the companies’ worldwide which are also accelerating the excipients market.
For instance,
- In September 2020, Roquette Frères has entered into a partnership with Barentz for pharmaceuticals distribution in the U.S. Both these companies are working in European markets creating distribution channel. This partnership will increase product portfolio of the company.
Partnership, new product development and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for excipients through expanded range of size.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA EXCIPIENTS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 ORIGIN LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 NORTH AMERICA EXCIPIENTS MARKET: COUNTRIES WITH DATA OF IMPORTS AND EXPORTS
4.2 NORTH AMERICA EXCIPIETNS MARKET: COLOMBIA DATA OF THE ORIGIN COUNTRY OF THE IMPORTS
4.3 NORTH AMERICA EXCIPIENTS MARKET: COLOMBIA DATA OF THE IMPORTS AND EXPORTS BY MOLECULES IN VALUES AND VOLUMES
5 NORTH AMERICA EXCIPIENTS MARKET: REGULATORY SCENARIO
5.1 THE CANADA REGULATORY GUIDANCE FOR NON CLINICAL SAFETY EVALUATION OF PHARMACEUTICAL EXCIPIENTS
5.2 JAPAN REGULATORY FRAMEWORK FOR EXCIPIENTS
5.3 MIDDLE EAST AND AFRICA REGULATORY FRAMEWORK FOR EXCIPIENTS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 TECHNOLOGICAL ADVANCEMENTS IN MULTIFUNCTIONAL EXCIPIENTS
6.1.2 INCREASING NEED FOR PHARMACEUTICAL PRODUCTS ACROSS VARIED THERAPEUTIC AREAS
6.1.3 INNOVATIONS IN BIOPHARMACEUTICALS
6.1.4 INCREASING DEMAND & AVAILABILITY OF GENERIC DRUGS
6.1.5 RISING FOCUS ON ORPHAN DRUGS
6.2 RESTRAINTS
6.2.1 STRINGENT REGULATIONS
6.2.2 LONG DURATION OF DRUG DEVELOPMENT PROCESS
6.2.3 HIGH COST OF EXPERIMENTAL STUDIES OF EXCIPIENTS
6.3 OPPORTUNITIES
6.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS
6.3.2 RISING DEMAND FOR EASE OF USE
6.3.3 RISING DISPOSABLE INCOME
6.3.4 INCREASING DEMAND FOR ALTERNATIVE ROUTES OF DELIVERY/DOSAGE FORMS
6.3.5 ASSOCIATED SIDE EFFECTS
6.3.6 SAFETY CONSIDERATION IN STORAGE & TRANSPORTATION
6.3.7 LACK OF NOVEL PHARMACEUTICAL EXCIPIENTS
7 IMPACT OF COVID-19 ON NORTH AMERICA EXCIPIENTS MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 MPACT ON SUPPLY CHAIN
7.4 STRATEGIC DECISION BY MANUFACTURERS
7.5 KEY INITIATIVES BY MARKET PLAYERS DURING COVID-19
7.6 CONCLUSION
8 NORTH AMERICA EXCIPIENTS MARKET, BY ORIGIN
8.1 OVERVIEW
8.2 ORGANIC
8.3 INORGANIC
9 NORTH AMERICA EXCIPIENTS MARKET, BY CATEGORY
9.1 OVERVIEW
9.2 PRIMARY EXCIPIENTS
9.3 SECONDARY EXCIPIENTS
10 NORTH AMERICA EXCIPIENTS MARKET, BY PRODUCTS
10.1 OVERVIEW
10.2 POLYMERS
10.2.1 MCC
10.2.2 HPMC
10.2.3 ETHYL CELLULOSE
10.2.4 METHYL CELLULOSE
10.2.5 CMC
10.2.6 CROSCARMELLOSE SODIUM
10.2.7 POVIDONE
10.2.8 PREGELATINIZED STARCH
10.2.9 SODIUM STARCH GLYCOL
10.2.10 POLYETHYLENE GLYCOL
10.2.11 ACRYLIC POLYMERS
10.3 SUGAR
10.3.1 LACTOSE
10.3.2 SUCROSE
10.3.3 OTHERS
10.4 ALCOHOL
10.4.1 PROPYLENE GLYCOL
10.4.2 SORBITOL
10.4.3 MANNITOL
10.4.4 GLYCERIN
10.4.5 OTHERS
10.5 MINERALS
10.5.1 CALCIUM PHOSPHATE
10.5.2 CALCIUM CARBONATE
10.5.3 CLAY
10.5.4 SILICON DIOXIDE
10.5.5 TITANIUM DIOXIDE
10.5.6 OTHERS
10.6 GELATIN
10.7 OTHERS
11 NORTH AMERICA EXCIPIENTS MARKET, BY CHEMISTRY TYPE
11.1 OVERVIEW
11.2 PLANT
11.3 ANIMALS
11.4 SYNTHETIC
11.5 MINERALS
12 NORTH AMERICA EXCIPIENTS MARKET, BY CHEMISTRY SYNTHESIS
12.1 OVERVIEW
12.2 LACTOSE MONOHYDRATE
12.3 SUCRALOSE
12.4 POLYSORBATE
12.5 BENZYL ALCOHOL
12.6 CETOSTEARY ACLOHOL
12.7 SOY LECITHIN
12.8 PREGELATINIZED STARCH
12.9 OTHERS
13 NORTH AMERICA EXCIPIENTS MARKET, BY FUNCTIONALITY
13.1 OVERVIEW
13.2 BINDERS AND ADHESIVES
13.3 DISINTEGRANTS
13.4 COATING MATERIAL
13.5 COLORING AGENTS
13.6 SOLUBILIZERS
13.7 FLAVORS
13.8 SWEETENING AGENTS
13.9 DILUENTS
13.1 LUBRICANTS
13.11 BUFFERS
13.12 EMULSIFYING AGENTS
13.13 PRESERVATIVES
13.14 ANTIOXIDANTS
13.15 SORBENTS
13.16 SOLVENTS
13.17 EMOLLIENTS
13.18 GLIDIENTS
13.19 CHELATING AGENTS
13.2 ANTIFOAMING AGENTS
13.21 OTHERS
14 NORTH AMERICA EXCIPIENTS MARKET, BY DOSAGE FORM
14.1 OVERVIEW
14.2 SOLID
14.2.1 PLANT
14.2.2 ANIMALS
14.2.3 SYNTHETIC
14.2.4 MINERALS
14.3 SEMI-SOLID
14.3.1 PLANT
14.3.2 ANIMALS
14.3.3 SYNTHETIC
14.3.4 MINERALS
14.4 LIQUID
14.4.1 PLANT
14.4.2 ANIMALS
14.4.3 SYNTHETIC
14.4.4 MINERALS
15 NORTH AMERICA EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION
15.1 OVERVIEW
15.2 ORAL EXCIPIENTS
15.3 TOPICAL EXCIPIENTS
15.4 PARENTERAL EXCIPIENTS
15.5 OTHER EXCIPIENTS
16 NORTH AMERICA EXCIPIENTS MARKET, BY END USER
16.1 OVERVIEW
16.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
16.3 CONTRACT FORMULATORS
16.4 RESEARCH ORGANIZATION AND ACADEMICS
16.5 OTHERS
17 NORTH AMERICA EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL
17.1 OVERVIEW
17.2 DIRECT TENDER
17.3 RETAIL SALES
17.4 OTHERS
18 NORTH AMERICA EXCIPIENTS MARKET, BY GEOGRAPHY
18.1 NORTH AMERICA
18.1.1 U.S.
18.1.2 CANADA
18.1.3 MEXICO
19 NORTH AMERICA EXCIPIENTS MARKET: COMPANY LANDSCAPE
19.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
20 SWOT ANALYSIS
21 COMPANY PROFILES
21.1 DOW
21.1.1 COMPANY SNAPSHOT
21.1.2 REVENUE ANALYSIS
21.1.3 COMPANY SHARE ANALYSIS
21.1.4 PRODUCT PORTFOLIO
21.1.5 RECENT DEVELOPMENTS
21.2 ROQUETTE FRÈRES
21.2.1 COMPANY SNAPSHOT
21.2.2 COMPANY SHARE ANALYSIS
21.2.3 PRODUCT PORTFOLIO
21.2.4 RECENT DEVELOPMENTS
21.3 JRS PHARMA
21.3.1 COMPANY SNAPSHOT
21.3.2 COMPANY SHARE ANALYSIS
21.3.3 PRODUCT PORTFOLIO
21.3.4 RECENT DEVELOPMENTS
21.4 EVONIK INDUSTRIES AG
21.4.1 COMPANY SNAPSHOT
21.4.2 REVENUE ANALYSIS
21.4.3 COMPANY SHARE ANALYSIS
21.4.4 PRODUCT PORTFOLIO
21.4.5 RECENT DEVELOPMENTS
21.5 THE LUBRIZOL CORPORATION (A SUBSIDIARY OF BERKSHIRE HATHAWAY INC.)
21.5.1 COMPANY SNAPSHOT
21.5.2 REVENUE ANALYSIS
21.5.3 COMPANY SHARE ANALYSIS
21.5.4 PRODUCT PORTFOLIO
21.5.5 RECENT DEVELOPMENT
21.6 BASF SE
21.6.1 COMPANY SNAPSHOT
21.6.2 REVENUE ANALYSIS
21.6.3 PRODUCT PORTFOLIO
21.6.4 RECENT DEVELOPMENTS
21.7 ASHLAND
21.7.1 COMPANY SNAPSHOT
21.7.2 REVENUE ANALYSIS
21.7.3 PRODUCT PORTFOLIO
21.7.4 RECENT DEVELOPMENTS
21.8 KERRY GROUP PLC
21.8.1 COMPANY SNAPSHOT
21.8.2 REVENUE ANALYSIS
21.8.3 PRODUCT PORTFOLIO
21.8.4 RECENT DEVELOPMENTS
21.9 SHIN-ETSU CHEMICAL CO., LTD.
21.9.1 COMPANY SNAPSHOT
21.9.2 REVENUE ANALYSIS
21.9.3 PRODUCT PORTFOLIO
21.9.4 RECENT DEVELOPMENTS
21.1 COLORCON
21.10.1 COMPANY SNAPSHOT
21.10.2 PRODUCT PORTFOLIO
21.10.3 RECENT DEVELOPMENTS
21.11 ADM
21.11.1 COMPANY SNAPSHOT
21.11.2 REVENUE ANALYSIS
21.11.3 PRODUCT PORTFOLIO
21.11.4 RECENT DEVELOPMENTS
21.12 AVANTOR, INC.
21.12.1 COMPANY SNAPSHOT
21.12.2 REVENUE ANALYSIS
21.12.3 PRODUCT PORTFOLIO
21.12.4 RECENT DEVELOPMENTS
21.13 BENEO
21.13.1 COMPANY SNAPSHOT
21.13.2 PRODUCT PORTFOLIO
21.13.3 RECENT DEVELOPMENTS
21.14 CHEMISCHE FABRIK BUDENHEIM
21.14.1 COMPANY SNAPSHOT
21.14.2 PRODUCT PORTFOLIO
21.14.3 RECENT DEVELOPMENTS
21.15 CRODA INTERNATIONAL PLC
21.15.1 COMPANY SNAPSHOT
21.15.2 REVENUE ANALYSIS
21.15.3 PRODUCT PORTFOLIO
21.15.4 RECENT DEVELOPMENTS
21.16 DFE PHARMA
21.16.1 COMPANY SNAPSHOT
21.16.2 PRODUCT PORTFOLIO
21.16.3 RECENT DEVELOPMENTS
21.17 MEGGLE GROUP WASSERBURG
21.17.1 COMPANY SNAPSHOT
21.17.2 PRODUCT PORTFOLIO
21.17.3 RECENT DEVELOPMENTS
21.18 OMYA AG
21.18.1 COMPANY SNAPSHOT
21.18.2 PRODUCT PORTFOLIO
21.18.3 RECENT DEVELOPMENTS
21.19 PETER GREVEN GMBH & CO. KG
21.19.1 COMPANY SNAPSHOT
21.19.2 PRODUCT PORTFOLIO
21.19.3 RECENT DEVELOPMENTS
21.2 PFANSTIEHL, INC.
21.20.1 COMPANY SNAPSHOT
21.20.2 PRODUCT PORTFOLIO
21.20.3 RECENT DEVELOPMENTS
22 QUESTIONNAIRE
23 RELATED REPORTS
Список таблиц
TABLE 1 NORTH AMERICA EXCIPIENTS MARKET, BY ORIGIN, 2017-2028 (USD MILLION)
TABLE 2 NORTH AMERICA ORGANIC IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 3 NORTH AMERICA INORGANIC IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 4 NORTH AMERICA EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 5 NORTH AMERICA PRIMARY EXCIPIENTS IN EXCIPIENT MARKETS, BY REGION, 2017-2028 (USD MILLION)
TABLE 6 NORTH AMERICA SECONDARY EXCIPIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 7 NORTH AMERICA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 8 NORTH AMERICA POLYMERS EXCIPIENTS IN EXCIPIENT MARKETS, BY REGION, 2017-2028 (USD MILLION)
TABLE 9 NORTH AMERICA POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 10 NORTH AMERICA SUGARS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 11 NORTH AMERICA SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 12 NORTH AMERICA ALCOHOLS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 13 NORTH AMERICA ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 14 NORTH AMERICA MINERALS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 15 NORTH AMERICA MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 16 NORTH AMERICA GELATIN IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 17 NORTH AMERICA OTHERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 18 NORTH AMERICA EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 19 NORTH AMERICA PLANT IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 20 NORTH AMERICA ANIMALS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 21 NORTH AMERICA SYNTHETIC IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 22 NORTH AMERICA MINERALS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 23 NORTH AMERICA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 24 NORTH AMERICA LACTOSE MONOHYDRATE IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 25 NORTH AMERICA SUCRALOSE IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 26 NORTH AMERICA POLYSORBATE IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 27 NORTH AMERICA BENZYL ALCOHOL IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 28 NORTH AMERICA CETOSTEARY ACLOHOL IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 29 NORTH AMERICA SOY LECITHIN IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 30 NORTH AMERICA PREGELATINIZED STARCH IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 31 NORTH AMERICA OTHERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 32 NORTH AMERICA EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 33 NORTH AMERICA BINDERS AND ADHESIVES IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 34 NORTH AMERICA DISINTEGRANTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 35 NORTH AMERICA COATING MATERIAL IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 36 NORTH AMERICA COLORING AGENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 37 NORTH AMERICA SOLUBILIZERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 38 NORTH AMERICA FLAVORS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 39 NORTH AMERICA SWEETENING AGENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 40 NORTH AMERICA DILUENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 41 NORTH AMERICA LUBRICANTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 42 NORTH AMERICA BUFFERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 43 NORTH AMERICA EMULSIFYING AGENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 44 NORTH AMERICA PRESERVATIVES IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 45 NORTH AMERICA ANTIOXIDANTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 46 NORTH AMERICA SORBENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 47 NORTH AMERICA SOLVENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 48 NORTH AMERICA EMOLLIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 49 NORTH AMERICA GLIDIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 50 NORTH AMERICA CHELATING AGENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 51 NORTH AMERICA ANTIFOAMING AGENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 52 NORTH AMERICA OTHERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 53 NORTH AMERICA EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 54 NORTH AMERICA SOLID IN EXCIPIENT MARKETS, BY REGION, 2017-2028 (USD MILLION)
TABLE 55 NORTH AMERICA SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 56 NORTH AMERICA SEMI- SOLID IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 57 NORTH AMERICA SEMI- SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 58 NORTH AMERICA LIQUID IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 59 NORTH AMERICA LIQUID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 60 NORTH AMERICA EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 61 NORTH AMERICA ORAL EXCIPIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 62 NORTH AMERICA TOPICAL EXCIPIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 63 NORTH AMERICA PARENTERAL EXCIPIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 64 NORTH AMERICA OTHER EXCIPIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 65 NORTH AMERICA EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 66 NORTH AMERICA PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 67 NORTH AMERICA CONTRACT FORMULATORS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 68 NORTH AMERICA RESEARCH ORGANIZATION AND ACADEMICS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 69 NORTH AMERICA OTHERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 70 NORTH AMERICA EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2017-2028 (USD MILLION)
TABLE 71 NORTH AMERICA DIRECT TENDER IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 72 NORTH AMERICA RETAIL SALES IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 73 NORTH AMERICA OTHERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 74 NORTH AMERICA EXCIPIENTS MARKET, BY COUNTRY, 2017-2028 (USD MILLION)
TABLE 75 NORTH AMERICA EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 76 NORTH AMERICA EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 77 NORTH AMERICA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 78 NORTH AMERICA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 79 NORTH AMERICA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 80 NORTH AMERICA POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 81 NORTH AMERICA SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 82 NORTH AMERICA ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 83 NORTH AMERICA MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 84 NORTH AMERICA EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 85 NORTH AMERICA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 86 NORTH AMERICA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 87 NORTH AMERICA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 88 NORTH AMERICA EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 89 NORTH AMERICA EXCIPIENTS MARKET, BY DOSAGE FORM, 2017-2028 (USD MILLION)
TABLE 90 NORTH AMERICA SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORM, 2017-2028 (USD MILLION)
TABLE 91 NORTH AMERICA SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 92 NORTH AMERICA LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 93 NORTH AMERICA EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 94 NORTH AMERICA EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 95 NORTH AMERICA EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 96 U.S. EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 97 U.S. EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 98 U.S. EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 99 U.S. EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 100 U.S. EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 101 U.S. POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 102 U.S. SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 103 U.S. ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 104 U.S. MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 105 U.S. EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 106 U.S. EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 107 U.S. EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 108 U.S. EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 109 U.S. EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 110 U.S. EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 111 U.S. SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 112 U.S. SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 113 U.S. LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 114 U.S. EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 115 U.S. EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 116 U.S. EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 117 CANADA EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 118 CANADA EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 119 CANADA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 120 CANADA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 121 CANADA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 122 CANADA POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 123 CANADA SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 124 CANADA ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 125 CANADA MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 126 CANADA EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 127 CANADA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 128 CANADA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 129 CANADA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 130 CANADA EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 131 CANADA EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 132 CANADA SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 133 CANADA SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 134 CANADA LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 135 CANADA EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 136 CANDA EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 137 CANADA EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 138 MEXICO EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 139 MEXICO EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 140 MEXICO EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 141 MEXICO EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 142 MEXICO EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 143 MEXICO POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 144 MEXICO SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 145 MEXICO ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 146 MEXICO MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 147 MEXICO EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 148 MEXICO EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 149 MEXICO EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 150 MEXICO EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 151 MEXICO EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 152 MEXICO EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 153 MEXICO SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 154 MEXICO SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 155 MEXICO LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 156 MEXICO EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 157 MEXICO EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 158 MEXICO EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
Список рисунков
FIGURE 1 NORTH AMERICA EXCIPIENTS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA EXCIPIENTS MARKET : DATA TRIANGULATION
FIGURE 3 NORTH AMERICA EXCIPIENTS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA EXCIPIENTS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA EXCIPIENTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA EXCIPIENTS MARKET: MULTIVARIATE MODELLING
FIGURE 7 NORTH AMERICA EXCIPIENTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA EXCIPIENTS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA EXCIPIENTS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 NORTH AMERICA EXCIPIENTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 NORTH AMERICA IS EXPECTED TO DOMINATE THE NORTH AMERICA EXCIPIENTS MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 TECHNOLOGICAL ADVANCEMENTS IN MULTIFUNCTIONAL EXCIPIENTS AND INNOVATION IN BIOPHARMACEUTICALS IS DRIVING THE NORTH AMERICA EXCIPIENTS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 ORGANIC SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA EXCIPIENTS MARKET IN 2021 & 2028
FIGURE 14 NORTH AMERICA IS THE FASTEST GROWING MARKET FOR EXCIPIENTS MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE NORTH AMERICA EXCIPIENTS MARKET
FIGURE 16 APPROVAL OF GENERIC MEDICINES BY USFDA
FIGURE 17 NORTH AMERICA EXCIPIENTS MARKET: BY ORIGIN, 2020
FIGURE 18 NORTH AMERICA EXCIPIENTS MARKET: BY ORIGIN, 2020-2028 (USD MILLION)
FIGURE 19 NORTH AMERICA EXCIPIENTS MARKET: BY ORIGIN, CAGR (2020-2028)
FIGURE 20 NORTH AMERICA EXCIPIENTS MARKET: BY ORIGIN, LIFELINE CURVE
FIGURE 21 NORTH AMERICA EXCIPIENTS MARKET: BY CATEGORY, 2020
FIGURE 22 NORTH AMERICA EXCIPIENTS MARKET: BY CATEGORY, 2020-2028 (USD MILLION)
FIGURE 23 NORTH AMERICA EXCIPIENTS MARKET: BY CATEGORY, CAGR (2020-2028)
FIGURE 24 NORTH AMERICA EXCIPIENTS MARKET: BY CATEGORY, LIFELINE CURVE
FIGURE 25 NORTH AMERICA EXCIPIENTS MARKET: BY PRODUCTS, 2020
FIGURE 26 NORTH AMERICA EXCIPIENTS MARKET: BY PRODUCTS, 2020-2028 (USD MILLION)
FIGURE 27 NORTH AMERICA EXCIPIENTS MARKET: BY PRODUCTS, CAGR (2020-2028)
FIGURE 28 NORTH AMERICA EXCIPIENTS MARKET: BY PRODUCTS, LIFELINE CURVE
FIGURE 29 NORTH AMERICA EXCIPIENTS MARKET: BY CHEMISTRY TYPE, 2020
FIGURE 30 NORTH AMERICA EXCIPIENTS MARKET: BY CHEMISTRY TYPE, 2020-2028 (USD MILLION)
FIGURE 31 NORTH AMERICA EXCIPIENTS MARKET: BY CHEMISTRY TYPE, CAGR (2020-2028)
FIGURE 32 NORTH AMERICA EXCIPIENTS MARKET: BY CHEMISTRY TYPE, LIFELINE CURVE
FIGURE 33 NORTH AMERICA EXCIPIENTS MARKET: BY CHEMICAL SYNTHESIS, 2020
FIGURE 34 NORTH AMERICA EXCIPIENTS MARKET: BY CHEMICAL SYNTHESIS, 2020-2028 (USD MILLION)
FIGURE 35 NORTH AMERICA EXCIPIENTS MARKET: BY CHEMICAL SYNTHESIS, CAGR (2020-2028)
FIGURE 36 NORTH AMERICA EXCIPIENTS MARKET: BY CHEMICAL SYNTHESIS, LIFELINE CURVE
FIGURE 37 NORTH AMERICA EXCIPIENTS MARKET: BY FUNCTIONALITY, 2020
FIGURE 38 NORTH AMERICA EXCIPIENTS MARKET: BY FUNCTIONALITY, 2020-2028 (USD MILLION)
FIGURE 39 NORTH AMERICA EXCIPIENTS MARKET: BY FUNCTIONALITY, CAGR (2020-2028)
FIGURE 40 NORTH AMERICA EXCIPIENTS MARKET: BY FUNCTIONALITY, LIFELINE CURVE
FIGURE 41 NORTH AMERICA EXCIPIENTS MARKET: BY DOSAGE FORMS, 2020
FIGURE 42 NORTH AMERICA EXCIPIENTS MARKET: BY DOSAGE FORMS, 2020-2028 (USD MILLION)
FIGURE 43 NORTH AMERICA EXCIPIENTS MARKET: BY DOSAGE FORMS, CAGR (2020-2028)
FIGURE 44 NORTH AMERICA EXCIPIENTS MARKET: BY DOSAGE FORMS, LIFELINE CURVE
FIGURE 45 NORTH AMERICA EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, 2020
FIGURE 46 NORTH AMERICA EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, 2020-2028 (USD MILLION)
FIGURE 47 NORTH AMERICA EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2020-2028)
FIGURE 48 NORTH AMERICA EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 49 NORTH AMERICA EXCIPIENTS MARKET: BY END USER, 2020
FIGURE 50 NORTH AMERICA EXCIPIENTS MARKET: BY END USER, 2020-2028 (USD MILLION)
FIGURE 51 NORTH AMERICA EXCIPIENTS MARKET: BY END USER, CAGR (2020-2028)
FIGURE 52 NORTH AMERICA EXCIPIENTS MARKET: BY END USER, LIFELINE CURVE
FIGURE 53 NORTH AMERICA EXCIPIENTS MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 54 NORTH AMERICA EXCIPIENTS MARKET: BY DISTRIBUTION CHAN, 2020-2028 (USD MILLION)
FIGURE 55 NORTH AMERICA EXCIPIENTS MARKET: BY DISTRIBUTION CHAN, CAGR (2020-2028)
FIGURE 56 NORTH AMERICA EXCIPIENTS MARKET: BY DISTRIBUTION CHAN, LIFELINE CURVE
FIGURE 57 NORTH AMERICA EXCIPIENTS MARKET: SNAPSHOT (2020)
FIGURE 58 NORTH AMERICA EXCIPIENTS MARKET: BY COUNTRY (2020)
FIGURE 59 NORTH AMERICA EXCIPIENTS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 60 NORTH AMERICA EXCIPIENTS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 61 NORTH AMERICA EXCIPIENTS MARKET: BY ORIGIN (2021-2028)
FIGURE 62 NORTH AMERICA EXCIPIENTS MARKET: COMPANY SHARE 2020 (%)
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
